Trial intelligence / Profile preview

Effect of Antibiotic Eye Drops on Nasal Microbiome

NCT05287425Phase 2Completed

Sponsor
Medical University of Vienna
Start
Aug 2019
Primary completion
Aug 2023
Modality
Nanoparticles, Implantable Devices, Transdermal Patches
Countries
1
01

Overview

A Phase 2 trial of gentamicin, ciprofloxacin in bacterial conjunctivitis (BC), keratitis, sponsored by Medical University of Vienna. Started Aug 2019; status: completed.

02

Drugs

gentamicinciprofloxacin
03

Conditions

bacterial conjunctivitis (BC)keratitis

Beyond the preview

Go deeper on NCT05287425.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05287425.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call